Molecular Imaging: Page 2

Clarity highlights Cu-64 PSMA-PET/CT study results

By AuntMinnieEurope.com staff writers

The study compares Clarity's copper-64 (Cu-64) SAR-bisPSMA PET/CT agent with standard gallium-68 PSMA-11 PET/CT.

March 18, 2026

Video from ECR: 'The Stone Age didn’t end because of a lack of stones'

In an interview at ECR, Dr. Andrei Iagaru, discussed the status of gamma-emitting imaging in theranostics and its future potential.

March 6, 2026

ECR: FDG-PET/CT biomarkers predict outcomes in lymphoma patients

Novel quantitative biomarkers may provide complementary insights into tumor burden and dissemination to improve treatment strategies.

March 4, 2026

Ecr 2026 Welcome Thumbnail

ECR: PET/CT useful for assessing sarcopenia in cancer patients

Incorporating body composition analysis into routine PET/CT reporting could be a pragmatic, high-yield step toward precision oncology.

March 4, 2026

DeepHealth TechLive remote imaging solution wins CE Mark

By AuntMinnieEurope.com staff writers

DeepHealth has secured a CE Mark for its TechLive remote imaging and radiology management solution, enabling commercialization in Europe.

February 27, 2026

Global groups seek to expand access to theranostics

By AuntMinnieEurope.com staff writers

The International Centers for Precision Oncology Foundation and the World Federation of Nuclear Medicine and Biology are collaborating to expand access to theranostics.

February 27, 2026

Global Connections

Nuclear medicine group CEI joins Vidi imaging network

By AuntMinnieEurope.com staff writers

France's Vidi cooperative imaging network has welcomed its first nuclear medicine group, Centre d'Explorations Isotopiques (CEI).

February 23, 2026

France Flag Button 400

Unfilled vacancies and disparities persist in nuclear medicine

By Maryam Payne

Nuclear medicine specialists have high career satisfaction, but unfilled vacancies and career disparities persist, finds a workforce survey by the European Association of Nuclear Medicine (EANM).

February 19, 2026

Nuclear Medicine Worker Sm

PET develops key clinical role in neuroendocrine tumors

By Edna Astbury-Ward, PhD

Dual PET imaging and the NETPET score are proving increasingly useful in the prognosis and treatment of neuroendocrine tumors.

February 19, 2026

Dual PET imaging in Case Two illustrates a patient with discordant disease. FDG PET (b & d) shows FDG uptake in tail of pancreas primary lesion (yellow arrow), as well as multiple hepatic metastases (yellow boxes), with enlarged liver span. DOTATATE PET on left (a) shows several hepatic metastases that do not demonstrate DOTATATE uptake above background of liver parenchyma. The liver lesions in (c) demonstrate moderate FDG uptake in liver lesions, with no corresponding DOTATATE avidity (white box) or central photopenia (white arrow). This discordance in dual PET imaging corresponds to a NETPET score of 5. This suggests de-differentiated disease and a less favorable prognosis. The patient was not suitable for Lutate treatment and received chemotherapy.

Eckert & Ziegler, Czech facility increase Ac-225 production

By AuntMinnieEurope.com staff writers

Eckert & Ziegler and the Nuclear Physics Institute of the Czech Academy of Sciences have increased production of actinium-225 (Ac-225) at two manufacturing sites.

February 18, 2026

Atom Nuclear Lab 400

PET/CT visualizes complications in patients on hemodialysis

F-18 sodium fluoride PET/CT scans can quantify changes in cardiac and aortic vascular calcifications.

February 18, 2026

2026 02 09 Pet Calcification Thumbnail

European to become chief editor of Journal of Nuclear Medicine

By AuntMinnieEurope.com staff writers

Prof. Dr. Ken Herrmann, chair of nuclear medicine at Universitätsklinikum Essen in Germany, will be the next editor in chief of the Journal of Nuclear Medicine.

February 12, 2026

Herrman Ken Thumbnail

Page 2 of 126